Cite
HARVARD Citation
Tabernero, J. et al. (n.d.). Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial. Lancet oncology. 16 (8), pp. 937-948. [Online].